@article{cbc8051a11b94f8d816f75b2ee8de35e,
title = "Dupilumab and Alopecia: Causative or Therapeutic?",
author = "Hendricks, \{Aleksi J.\} and Lio, \{Peter A.\} and Shi, \{Vivian Yan\}",
note = "Funding Information: V.Y.S. is a stock shareholder of Dermveda, has served as a paid advisor for Sanofi, Novartis, SUN Pharma, Pfizer, Menlo Therapeutics, GpSkin, the National Eczema Association and Global Parents for Eczema Research, is an investigator for AbbVie and Leo Pharma, and has received research funding from the Foundation for Atopic Dermatitis and Skin Actives Scientific. There were no incentives or transactions financial or otherwise relevant to this paper. P.A.L. has served as an investigator, speaker, advisory board member and consultant for Sanofi Gen-zyme/Regeneron. There were no incentives or transactions financial or otherwise relevant to this paper. A.J.H. has no conflicts of interest to declare.",
year = "2019",
month = jul,
day = "1",
doi = "10.1159/000499080",
language = "English",
volume = "235",
pages = "306--307",
journal = "Dermatology",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "4",
}